# Centralized Tumour Board and Secondary Intervention Rate in mCRC

> **NCT04852250** · — · UNKNOWN · sponsor: **Ludwig-Maximilians - University of Munich** · enrollment: 130 (estimated)

## Conditions studied

- Metastatic Colorectal Cancer
- RAS Mutation
- Multidisciplinary Communication
- Secondary Intervention

## Interventions

- **OTHER:** Virtual centralized multidisciplinary tumour board

## Key facts

- **NCT ID:** NCT04852250
- **Lead sponsor:** Ludwig-Maximilians - University of Munich
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-06-01
- **Primary completion:** 2023-03-31
- **Final completion:** 2025-03-31
- **Target enrollment:** 130 (ESTIMATED)
- **Last updated:** 2021-04-21

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04852250

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04852250, "Centralized Tumour Board and Secondary Intervention Rate in mCRC". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT04852250. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*